No Data
Liaoning He Eye Hospital Group Co., LTD.'s (SZSE:301103) Most Bullish Insider, CEO Wei He Must Be Pleased With the Recent 18% Gain
Ho\'s Ophthalmology: 2024 Annual Report
Ho\'s Ophthalmology: 2024 Annual Report Summary
Ho\'s Ophthalmology: First Quarter Report 2025
He Family Ophthalmology (301103.SZ) released its first-quarter results, with a net income of 32.5319 million yuan, an increase of 12.27%.
He’s Eye Hospital (301103.SZ) released the first quarter report for 2025, with the company's revenue of 2.91...
Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.
In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.
Liaoning He Eye Hospital Group (SZSE:301103) Could Be Struggling To Allocate Capital
